Bupropion-SR plus naltrexone-SR for the treatment of mild-to-moderate obesity
- PMID: 26512740
- DOI: 10.1586/17512433.2016.1100072
Bupropion-SR plus naltrexone-SR for the treatment of mild-to-moderate obesity
Abstract
Naltrexone-bupropion is a recently approved drug combination for chronic weight management. In this article, we discuss the rationale for its use as a combination followed by a comprehensive review of safety and efficacy data from major preclinical, phase II and III clinical trials.
Keywords: Naltrexone; bupropion; obesity; type 2 diabetes; weight loss.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials